Merck & Co., Inc. EPS (Basic) 2007-2026 | MRK
Beta
What is eps (basic)?
Basic earnings per share (EPS) can be defined as net income divided by the weighted average number of common shares outstanding during a period.
What is Merck & Co., Inc.'s current eps (basic)?
Merck & Co., Inc. (MRK) annual eps (basic) for 2025 was $7.30, a 7.99% increase from 2024. Merck & Co., Inc. eps (basic) for the quarter ending March 31, 2026 was $-1.72.
What was Merck & Co., Inc.'s eps (basic) in 2024?
Merck & Co., Inc. annual eps (basic) for 2024 was $6.76, a 4728.57% increase from 2023.
What was Merck & Co., Inc.'s eps (basic) in 2023?
Merck & Co., Inc. annual eps (basic) for 2023 was $0.14, a 97.56% decline from 2022.
What is Merck & Co., Inc.'s 5-year eps (basic) CAGR?
Merck & Co., Inc. eps (basic) grew at a compound annual growth rate (CAGR) of 21.21% from FY2020 to FY2025, going from $2.79 to $7.30 over 5 years.
EPS (Basic) History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+21.2%
FY2020
$2.79
→
FY2025
$7.30
07080910111213141516171819202122232425
5 years selected
EPS (Basic) History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.30 | +8.0% | 10-K |
| FY2024 | $6.76 | +4728.6% | 10-K |
| FY2023 | $0.14 | -97.6% | 10-K |
| FY2022 | $5.73 | +11.0% | 10-K |
| FY2021 | $5.16 | +84.9% | 10-K |
| FY2020 | $2.79 | -27.3% | 10-K |
| FY2019 | $3.84 | +64.1% | 10-K |
| FY2018 | $2.34 | +165.9% | 10-K |
| FY2017 | $0.88 | -38.0% | 10-K |
| FY2016 | $1.42 | -10.1% | 10-K |
| FY2015 | $1.58 | -61.7% | 10-K |
| FY2014 | $4.12 | +176.5% | 10-K |
| FY2013 | $1.49 | -26.6% | 10-K |
| FY2012 | $2.03 | -0.5% | 10-K |
| FY2011 | $2.04 | +628.6% | 10-K |
| FY2010 | $0.28 | -95.1% | 10-K |
| FY2009 | $5.67 | +55.3% | 10-K |
| FY2008 | $3.65 | +141.7% | 10-K |
| FY2007 | $1.51 | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →